AFFF Defendants Move to Dismiss 10,000+ Plaintiffs Over Missing Medical Records

Defendants in the AFFF "forever chemicals" multidistrict litigation filed waves of dismissal motions in June 2026 targeting thousands of plaintiffs: first more than 8,000, then more than 10,000 additional names, for failing to produce required medical and exposure documentation. Law.com reported July 7 that oppositions were due mid-July, with defense counsel calling the filings "just the first wave." Meanwhile, MDL 2873 held approximately 15,244 pending cases as of the July 1, 2026 JPML count.

The personal injury track has produced no global settlement. Public water systems have recovered more than $12 billion from manufacturers, while individual cancer claimants have received none of those funds.

Case Background: Water Money, PI Deadlock

MDL 2873 is pending in the District of South Carolina before Judge Richard M. Gergel. The October 2025 personal-injury bellwether was vacated under CMO 35, and no replacement trial date has been set. A 28-case bellwether pool (covering kidney cancer, testicular cancer, thyroid disease, and ulcerative colitis) continues through case-specific discovery while the court clears the docket.

CMO 37: The Medical Records Cull

CMO 37 (February 25, 2026) created a formal process to identify plaintiffs missing Plaintiff Fact Sheets, profile forms, or, for cases filed after March 1, 2025, medical diagnosis and exposure documentation through the MDL portal. After a short cure period, defendants may seek dismissal without prejudice, with refiling restrictions that can convert failures into with-prejudice outcomes.

A special master was appointed in mid-June 2026 to review compliance disputes as motion practice scaled. The pattern mirrors other high-volume MDLs: rapid filing without rapid records production creates a dismissal funnel.

What This Means for Pending AFFF Inventories

Firms that signed firefighters, veterans, and base-adjacent residents during the CMO 35 surge now face a records race. Defendants are no longer waiting for bellwethers to thin inventory; they are using compliance orders.

Who Qualifies

Typical PI screening includes documented AFFF or PFAS exposure (firefighting, military aviation/crash response, airport/industrial use, or contaminated water) plus a qualifying diagnosis tracked in the MDL: commonly kidney cancer, testicular cancer, thyroid disease or cancer, ulcerative colitis, or liver cancer, subject to current case-management criteria.

Medical Records Needed

• Pathology and oncology records confirming diagnosis
• Treatment histories establishing severity and timeline
• Military records (DD-214, orders, MOS, training logs) for service exposure
• Civilian firefighter and airport employment records
• Primary-care and specialty records spanning exposure and latency periods

LlamaLab retrieves records in 4 days on average (with roughly 30-40% returned same-day on portal and electronic requests) and uses insurance data to surface treatment locations clients forget, helping firms assemble complete files across multi-decade histories. For broader PFAS settlement-deadline context, see LlamaLab's earlier PFAS litigation update.

Next Steps

Summary

The AFFF MDL's July 2026 development is not a settlement announcement. It is a records-compliance deadline inside a 15,000-case docket. Water providers already finalized settlements; individual plaintiffs must prove diagnosis and exposure to remain in the MDL.

Firms that complete medical and exposure packets now will protect their inventory from procedural dismissals.

Sources: Law.com (July 7, 2026), MDLUpdate MDL-2873, D.S.C. MDL portal / CMO 37, 3M water settlement approval, EPA PFAS drinking water rule. Case counts current as of July 1, 2026 JPML reporting.